Diabetic Urethropathy Compounds the Effects of Diabetic Cystopathy

Keyphrases

• Diabetic 100%
• Diabetes Mellitus Rats 100%
• Diabetic Cystopathy 100%
• Type 1 Diabetes Mellitus (T1DM) 57%
• Phenylephrine 42%
• Perfusion Pressure 42%
• Nω-nitro-L-arginine 42%
• Urethral muscle 42%
• Adrenergic Agonist 28%
• Smooth muscle Relaxation 28%
• α-bungarotoxin 28%
• Bladder Pressure 28%
• Bladder Contraction 28%
• Voiding Dysfunction 28%
• Artificial Urethral Sphincter 28%
• Early Intervention 14%
• Intervention Targets 14%
• Nitric Oxide 14%
• Skeletal muscle 14%
• Vicious Cycle 14%
• Sprague-Dawley Rats 14%
• Beta-blockers 14%
• Nitric Oxide Synthase Inhibitors 14%
• Age-matched 14%
• Massachusetts 14%
• Lower Urinary Tract 14%
• Wilmington 14%
• Charles River 14%
• Streptozotocin-induced Diabetes Mellitus 14%
• Long-term Diabetes 14%
• Urethane 14%
• Voiding Efficiency 14%
• Urethral Function 14%
• Sphincter Dysfunction 14%
• Sphincter Electromyography 14%
• Detrusor Sphincter Dyssynergia 14%
• Urethral Dysfunction 14%

Medicine and Dentistry

• Diabetes Mellitus 100%
• Arginine 27%
• Phenylephrine 27%
• Bladder 18%
• Sympathomimetic Drug 18%
• Smooth Muscle Relaxation 18%
• Bungarotoxin 18%
• Voiding Dysfunction 18%
• Sphincter 18%
• Nitric Oxide 9%
• Hypersensitivity 9%
• Smooth Muscle 9%
• Streptozotocin-Induced Diabetes Mellitus 9%
• Urinary Tract 9%
• Electromyography 9%
• Nitric Oxide Synthase Inhibitor 9%
• Early Intervention 9%
• Detrusor Dyssynergia 9%
• Urethan 9%
• Bladder Contraction 9%
• Skeletal Muscle 9%

Neuroscience

• Diabetes Mellitus 100%
• Arginine 25%
• Phenylephrine 25%
• Sympathomimetic Drug 16%
• Bungarotoxin 16%
• Nitric Oxide Synthase 8%
• Nitric Oxide 8%
• Streptozotocin 8%
• Skeletal Muscle 8%
• Ethyl Carbamate 8%
• Electromyography 8%